MyD88 is pivotal for immune recognition of Citrobacter koseri and astrocyte activation during CNS infection† by Liu, Shuliang & Kielian, Tammy
RESEARCH Open Access
MyD88 is pivotal for immune recognition of




1,3 and Tammy Kielian
2*
Abstract
Citrobacter koseri (C. koseri) is a Gram-negative bacterium that can cause a highly aggressive form of neonatal
meningitis, which often progresses to establish multi-focal brain abscesses. The roles of Toll-like receptor 4 (TLR4)
and its signaling adaptor MyD88 during CNS C. koseri infection have not yet been examined, which is important
since recent evidence indicates that innate immune responses are tailored towards specific pathogen classes. Here
TLR4 WT (C3H/FeJ) and TLR4 mutant (C3H/HeJ) mice as well as MyD88 KO animals were infected intracerebrally
with live C. koseri, resulting in meningitis and ventriculitis with accompanying brain abscess formation. MyD88 KO
mice were exquisitely sensitive to C. koseri, demonstrating enhanced mortality rates and significantly elevated
bacterial burdens compared to WT animals. Interestingly, although early proinflammatory mediator release (i.e.
12 h) was MyD88-dependent, a role for MyD88-independent signaling was evident at 24 h, revealing a
compensatory response to CNS C. koseri infection. In contrast, TLR4 did not significantly impact bacterial burdens
or proinflammatory mediator production in response to C. koseri. Similar findings were obtained with primary
astrocytes, where MyD88-dependent pathways were essential for chemokine release in response to intact C. koseri,
whereas TLR4 was dispensable; implicating the involvement of alternative TLRs since highly enriched astrocytes did
not produce IL-1 upon bacterial exposure, which also signals via MyD88. Collectively, these findings demonstrate
the importance of MyD88-dependent mechanisms in eliciting maximal proinflammatory responses, astrocyte
activation, and bacterial containment during CNS C. koseri infection, as well as a late-phase MyD88-independent
signaling pathway for cytokine/chemokine production.
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Introduction
Citrobacter koseri (formerly known as C. diversus)i sa
Gram-negative bacillus with a predilection for causing
meningitis and multi-focal brain abscesses in human
neonates [1,2]. In fact, almost one-third of infants and
young children infected with C. koseri succumb to the
disease, and approximately half of those who survive
infection experience long-term neurological deficits due
to focal or diffuse brain damage [1,2]. Increasing evi-
dence has accumulated demonstrating that innate
immune responses are tailored towards specific patho-
gen classes [3-5]. Specifically, the types of responses
elicited by Gram-positive bacteria can differ significantly
from those triggered by Gram-negative pathogens. In
addition, the majority of studies examining bacterial
pathogenesis in the CNS have utilized Gram-positive
organisms [6-8], which eliminates the involvement of
key Toll-like receptors (TLRs) that may trigger distinct
pathways during Gram-negative infections (i.e. TLR4,
TLR5). Therefore, it is important to investigate the CNS
response to divergent pathogens to identify unique as
well as conserved responses, which may facilitate the
development of novel treatment strategies that would
cross multiple bacterial species.
The innate immune system recognizes multiple patho-
gen classes via highly conserved molecular motifs,
termed pathogen-associated molecular patterns
(PAMPs), through a limited set of germ-line encoded
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[9,10]. Toll-like receptors (TLRs) are a family of PRRs
responsible for sensing numerous PAMPs of bacterial,
viral, and fungal species [9]. For example, lipoproteins
and LPS contained in the outer cell wall of Gram-nega-
tive bacteria are agonists for TLR2 and TLR4, respec-
tively; flagellin, which is the main component of
bacterial flagella, engages TLR5; and bacterial DNA con-
taining unmethylated CpG motifs binds to TLR9. Since
Citrobacter are Gram-negative bacilli and possess an
outer cell wall rich in LPS, it was anticipated that TLR4-
mediated signaling would be important in eliciting host
inflammatory responses. However, LPS is not the only
Citrobacter-derived PAMP that could be recognized by
the host. Other candidates include, but are not limited
to, lipoproteins, flagellin, and bacterial DNA that are
recognized by TLR2, TLR5, and TLR9, respectively.
Therefore, all of these TLRs could conceivably contri-
bute to activation of the host inflammatory response
during CNS C. koseri infection and since they all utilize
the common adaptor molecule myeloid differentiation
factor 88 (MyD88) [11,12], we also examined responses
to bacterial challenge in MyD88 KO mice.
Although their primary function is to provide support
for maintaining CNS homeostasis, astrocytes can also
participate in innate immune responses and serve as a
major source of chemokines [13,14]. Astrocytes express
TLRs and can clearly contribute to innate immune pro-
cesses in the CNS [13,15]. Although astrocytes are stra-
tegically positioned at the blood-brain barrier, a site
where C. koseri must traverse to colonize the CNS par-
enchyma during infection, to date no studies have exam-
ined whether astrocytes are capable of recognizing this
pathogen and the downstream consequences elicited. In
addition, since astrocytes are the most numerous cell
type in the CNS parenchyma these cells likely play a
major role in dictating the course of C. koseri ventriculi-
tis, meningitis, and brain abscess formation.
Following TLR engagement, a number of diverse sig-
naling pathways can be triggered, the nature of which
depends on the specific PAMP [9,16]. Most TLR-
mediated signaling pathways converge to utilize the
common intracellular adaptor molecule MyD88, with
the exception of TLR3. However, in addition to utilizing
MyD88, TLR4-mediated signaling can also occur
through alternative adapter molecules, namely TIR-
domain-containing adaptor protein-inducing IFN-b
(TRIF) and TRIF-related adaptor molecule (TRAM)
[9,16]. The MyD88-dependent pathway is responsible
for early-phase NF-B and MAPK activation, which
induces proinflammatory cytokine/chemokine expres-
sion. In contrast, the MyD88-independent, TRIF-depen-
dent pathway activates interferon regulatory factor 3
(IRF3), which is required for the expression of IFN-
inducible genes. Furthermore, this pathway mediates
late-phase NF-B as well as MAPK activation, also con-
tributing to inflammatory responses [17]. Since C. koseri
is a Gram-negative pathogen with abundant LPS in its
outer cell wall, it was important to consider the possible
contribution of MyD88-independent pathways for elicit-
ing inflammatory gene expression during CNS infection.
To assess the functional importance of TLR4 and
MyD88 in C. koseri-induced parenchymal infection,
TLR4 WT (C3H/FeJ) and TLR4 mutant (C3H/HeJ)
mice as well as MyD88 KO animals were infected intra-
cerebrally with live C. koseri. MyD88 KO mice were
exquisitely sensitive to C. koseri and succumbed to
infection within 24-36 h following bacterial exposure.
The enhanced mortality rate of MyD88 KO mice was
typified by significantly elevated bacterial burdens and
attenuated cytokine/chemokine expression and immune
cell influx early after infection (i.e. 12 h). Interestingly,
MyD88-independent pathways were triggered with a
delayed kinetics (i.e. 24 h), likely representing a compen-
satory mechanism in an attempt to contain infection. In
contrast to MyD88, TLR4 had minimal impact on bac-
terial burdens or proinflammatory mediator production.
Similar findings were obtained with astrocytes, where
MyD88-dependent signaling was essential for chemokine
production by C. koseri treated cells, whereas TLR4 was
dispensable. Collectively, these findings demonstrate the
importance of MyD88-dependent mechanisms in elicit-
ing maximal proinflammatory responses and bacterial
containment during CNS C. koseri infection, as well as a




MyD88 KO mice (kindly provided by Dr. Shizuo Akira,
Osaka University, Osaka, Japan) have been backcrossed
with C57BL/6 mice for over 10 generations and age-
and sex-matched C57BL/6 mice were purchased from
the National Cancer Institute (NCI-Frederick, Frederick,
MD) as WT controls. C3H/FeJ and C3H/HeJ mice were
purchased from the Jackson Laboratory (Bar Harbor,
ME). The C3H/HeJ strain carries a spontaneous muta-
tion in the cytoplasmic domain of TLR4 making it
unable to transduce a signal in response to LPS (here-
after referred to as TLR4 mutant) [18,19] and C3H/FeJ
mice were used as WT controls.
Ethical approval
The animal use protocols were approved by the Institu-
tional Animal Care and Use Committees at the Univer-
sity of Nebraska Medical Center and University of
Arkansas for Medical Sciences, and are in accord with
NIH guidelines for the use of rodents.
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C. koseri strain 4036 was originally isolated from the
cerebrospinal fluid of an infant with meningitis and
multiple brain abscesses [20] and was kindly provided
by Dr. J. G. Vallejo (Baylor College of Medicine, Hous-
ton, TX). Based on antibiotic sensitivity profiles (per-
formed by the Clinical Microbiology Laboratory at
Arkansas Children’s Hospital, Little Rock, AR), the
strain was propagated in the presence of ampicillin (20
μg/ml) in brain-heart infusion broth with constant agita-
tion (250 rpm) and recovered at mid-log-phase (12-18 h
incubation) by washing twice with ice-cold PBS. To pre-
pare live C. koseri stocks, freshly recovered bacteria
were resuspended in PBS containing 10% DMSO and
5% bovine serum albumin (Sigma-Aldrich, St. Louis,
MO) and aliquots stored at -80°C. Immediately before
infection, aliquots were washed twice with ice-cold PBS
to remove residual DMSO, serially diluted 10-fold in
PBS, and plated on blood agar plates to determine infec-
tious titers.
Generation of C. koseri-induced meningitis and brain
abscess
Age- and gender-matched TLR4 WT and TLR4 mutant,
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were used for in vivo studies to investigate C. koseri-
induced meningitis and brain abscess pathogenesis.
Briefly, live bacteria were directly inoculated into the
brain parenchyma by stereotactic injection as previously
described [21]. C. koseri was resuspended in PBS rather
than encapsulated in agarose beads, the latter of which
represents the standard method for inducing experimen-
tal brain abscesses [22]. The rationale for this approach
is that the meninges are punctured during intracerebral
injections and the introduction of bacteria in an aqueous
suspension allows for pathogen reflux into the subarach-
noid space via the needle tract, leading to meningitis
formation. This procedure recapitulates clinical disease
since many infants infected with C. koseri develop
meningitis and ventriculitis that is often complicated by
abscess formation [2]. Since pilot studies indicated that
MyD88 KO animals were extremely sensitive to
C. koseri, succumbing to infection within the first 24-36
h following bacterial exposure, MyD88 KO and WT
mice were euthanized at either 12 or 24 h post-infection
to eliminate potential bias from only examining animals
that had survived the infection (i.e. “survival bias”).
Preparation of brain homogenates for quantitation of
bacterial titers and proinflammatory mediator production
Mice were sacrificed with an overdose of inhaled isoflur-
ane and perfused transcardially with ice cold PBS. Both
the infected and contralateral hemispheres were col-
lected, weighed, and homogenized in 500 μlo f
homogenization buffer [1X PBS supplemented with a
protease inhibitor cocktail tablet (Roche, Indianapolis,
IN) and RNase inhibitor (Promega, Madison, WI)] on
ice. To quantitate the numbers of viable bacteria, serial
10-fold dilutions of brain tissue homogenates were pla-
ted onto blood agar. Titers were calculated by enumer-
ating colony growth and are expressed as colony
forming units (CFU) per gram wet tissue weight. Super-
natants were collected from brain homogenates follow-
ing centrifugation at 14,000 rpm for 20 min at 4°C for
downstream analyses of cytokine and chemokine expres-
sion by Milliplex multi-analyte bead arrays. Protein con-
centrations of brain homogenates were determined
using a colorimetric Bio-Rad DC Protein Assay kit as
specified by the manufacturer (Bio-Rad, Hercules, CA).
Milliplex multi-analyte bead array
To compare proinflammatory mediator expression profiles
between the various mutant and WT mice, a custom-
designed mouse cytokine/chemokine microbead array was
utilized according to the manufacturer’s instructions
(Milliplex; Millipore, Billerica, MA). This microbead array
allows for the simultaneous detection of 19 individual
inflammatory molecules in a single 75 μlb r a i nh o m o g e -
nate including IL-1a, IL-1b, TNF-a, IFN-g, IL-6, IL-9, IL-
10, IL-12p70, IL-12p40, IL-15, IL-17, CXCL1/keratinocyte
chemoattractant (KC), CXCL2/macrophage inflammatory
protein-2 (MIP-2), CXCL9/monokine induced by IFN-g
(MIG), CXCL10/IFN-g-induced protein 10 (IP-10), CCL2/
monocyte chemoattractant protein-1 (MCP-1), CCL3/
MIP-1a, CCL4/MIP-1b, and CCL5/regulated upon activa-
tion T cell expressed and secreted (RANTES). Results
were analyzed using a Bio-Plex workstation (Bio-Rad) and
adjusted based on the amount of total protein extracted
from brain tissue homogenates for normalization.
Quantitation of cellular infiltrates in C. koseri infected
brain tissues by FACS
To determine whether MyD88 loss affected neutrophil
or macrophage influx and/or microglial percentages fol-
lowing C. koseri infection, cells were quantitated by
FACS analysis as previously described [6,23]. Briefly,
mice were perfused with PBS to eliminate leukocytes
from the vasculature and both hemispheres were col-
lected to recover infection-associated cells. Brain tissues
were minced in HBSS supplemented with 10% FBS and
filtered through a 70 μm nylon mesh strainer. The
resulting tissue suspensions were digested for 30 min at
37°C in HBSS supplemented with collagenase type I
(Sigma-Aldrich) and DNase I (Invitrogen, San Diego,
CA; 2 mg/ml and 28 U/ml final concentrations, respec-
tively) to obtain a single-cell suspension. Following
enzyme neutralization, cells were layered onto a discon-
tinuous Percoll gradient (1.03-1.088 g/ml), whereupon
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face collected. Following extensive washes and incuba-
tion in Fc Block™ (BD Biosciences, San Diego, CA) to
minimize non-specific antibody binding to Fc receptors,
cells were stained with directly conjugated Abs (Ly-6G-
PE, F4/80-Alexa 488, and CD45-APC, all from BD Bios-
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low-intermediate).
The vital stain 7-AAD (eBiosciences, San Diego, CA)
was included to discriminate viable from dead cells.
Cells were analyzed using a BD FACSAria cytometer
(BD Biosciences) with compensation set based on the
staining of each individual fluorochrome alone and cor-
rection for autofluorescence with unstained cells. Con-
trols included cells stained with directly conjugated
isotype control Abs (BD Biosciences) to assess the
degree of nonspecific staining. Results are presented as
the percentage of viable neutrophils, macrophages, and
microglia recovered from MyD88 KO animals compared
to WT mice (set to 100%).
After sorting, viable neutrophils, macrophages, and
microglia recovered from C. koseri infected MyD88 WT
and KO mice were enumerated and added to 96-well
plates without further stimulation for 24 h, whereupon
conditioned medium was collected to quantitate proin-
flammatory mediator expression using Milli-Plex multi-
analyte bead arrays. Results are expressed as the concen-
tration of each inflammatory mediator per 10
3 cells for
normalization.
Processing of brain tissues for histological and
immunofluorescence analysis
Brain tissues were collected from C. koseri infected
MyD88 KO and WT animals at 24 h post-injection to
evaluate neuropathological changes. To prepare tissues
for immunostaining, mice were perfused with 4% par-
aformaldehyde (PFA) in 1X PBS using a peristaltic per-
fusion pump at a flow rate of 10 ml/min. Brain tissues
were post-fixed in cold 4% PFA for 1 h and cryopro-
tected in 30% sucrose prior to freezing and embedding
in OCT (Optimal Cutting Temperature compound,
Sakura Finetek USA Inc., Torrance, CA) for cryostat
sectioning. Serial sections of brain tissues (10 μm)
were prepared and processed for immunofluorescence
staining with Iba-1 (Biocare Medical, Concord, CA) to
assess microglial/macrophage reactivity and imaged
using a Zeiss LSM 510 META confocal microscope
(Zeiss, New York, NY). In addition, infected brain tis-
sues were processed for Gram staining to visualize
extracellular C. koseri and the extent of bacterial
dissemination.
Purification of primary astrocytes by FACS
Primary astrocytes were derived from mixed glial cul-
tures of TLR4 WT, TLR4 mutant, C57BL/6 WT, and
MyD88 KO mice (1-4 days of age) as previously
described [24]. One concern when working with primary
astrocytes relates to the issue of cell purity, principally
due to low levels of residual microglia [25]. Therefore,
after a minimum of three passages while cultured in the
presence of 0.1 mM L-LME, a microglial cytotoxic agent
[25,26], the resulting cells were stained with CD11b, a
cell surface marker expressed on microglia, but not
astrocytes, and collected by negative selection to obtain
highly enriched astrocytes. Briefly, cells were incubated
with Fc Block™ followed by a CD11b-PerCP-Cy5.5 anti-
body (both from BD Biosciences). Cells were sorted on a
FACSAria (BD Biosciences) at a low flow rate through a
large nozzle to minimize astrocyte damage during the
sorting procedure. Post-sort analysis revealed less than
1% contamination with CD11b
+ microglia. An additional
assessment of astrocyte purity after sorting was obtained
by culturing astrocytes on glass cover slips followed by
immunofluorescence staining with GFAP and CD11b
(Additional File 1, Figure S2).
Enzyme linked immunosorbent assay (ELISA)
Quantitation of CCL2 and TNF-a (mouse OptEIA, BD
Biosciences) and CXCL2 and IL-1b (mouse DuoSet; R &
D Systems, Minneapolis, MN) levels in conditioned
supernatants from astrocytes treated with C. koseri was
performed using standard sandwich ELISA kits accord-
ing to the manufacturer’s instructions.
Nitrite assay
Levels of nitrite, a stable end product of nitric oxide
(NO) following its reaction with O2, were quantitated
in conditioned supernatants of astrocytes treated with
C. koseri using the Griess reagent (0.1% naphtyletylene-
diamine dihydrochloride, 1% sulfanilamide, and 2.5%
phosphoric acid, all from Sigma). The absorbance at
550 nm was measured on a plate reader (Spectra Max
190; Molecular Devices, Sunnyvale, CA, USA), and
nitrite concentrations determined using a standard
curve with sodium nitrite (NaNO2;S i g m a ;l e v e lo fs e n -
sitivity 0.4 μM).
Statistical analysis
Significant differences were determined either by a Stu-
dent’s t-test or one-way analysis of variance (ANOVA)
followed by the Holm-Sidak method for multiple pair-
wise comparisons as indicated (SPSS Science, Chicago,
IL). For all analyses, a p-value of less than 0.05 was con-
sidered to be statistically significant.
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MyD88-dependent signals are critical for bacterial
containment and inflammatory mediator production
during C. koseri brain infection
To evaluate the functional importance of MyD88-depen-
dent pathways for CNS immune responses to C. koseri,
we employed a mouse model of meningitis and brain
abscess formation using a C. koseri clinical isolate [20].
After subjecting C57BL/6 mice to a series of escalating
inoculums, a dose of approximately 3 × 10
4 cfu resulted
in a 30% mortality rate concomitant with meningitis and
ventriculitis, and brain abscess formation in a subset of
animals (Additional File 2, Figure S1). Therefore, this
dose was used for all subsequent experiments.
MyD88 KO mice were exquisitely sensitive to intracer-
ebral C. koseri, with the majority of animals succumbing
to infection within 24-36 h following bacterial exposure
(data not shown). Because MyD88 was essential for sur-
vival, this dictated acute sampling intervals of 12 and 24
h following bacterial exposure to avoid potential artifacts
due to “survival bias”. Bacterial burdens were similar
between MyD88 KO and WT mice at 12 h post-infec-
tion (Figure 1A and 1B). In contrast, C. koseri titers
were significantly elevated in both the injected and con-
tralateral hemispheres of MyD88 KO mice at 24 h fol-
lowing bacterial exposure compared to WT animals
(Figure 1A and 1B), revealing a pivotal role for MyD88
in controlling C. koseri infection. This finding was cor-
roborated by Gram-staining, where MyD88 KO mice
exhibited greater extracellular C. koseri compared to
WT animals (Figure 1D and 1C, respectively). Collec-
tively, these findings reveal the critical role that MyD88-
dependent signals play in bacterial containment during
CNS C. koseri infection.
The dramatic sensitivity of MyD88 KO mice to
intracerebral C. koseri suggested defects in mounting a
protective antibacterial inflammatory response in the
CNS parenchyma. To examine this possibility, proin-
flammatory mediator expression was evaluated in
MyD88 KO and WT animals using a multi-analyte
bead array. Indeed, the expression of numerous cyto-
kines (i.e. IL-1b,T N F - a, and IL-6) and chemokines (i.
e. CXCL1, CXCL2, CXCL10, and CCL2) were signifi-
cantly attenuated in infected MyD88 KO mice at 12 h
following bacterial exposure, reflecting impaired
immune activation (Figure 2). Surprisingly, the levels
of these same mediators were significantly increased
in MyD88 KO animals at 24 h post-infection, suggest-
ing a late induction of MyD88-independent signaling
to elicit proinflammatory mediator release (Figure 2).
It is possible that this MyD88-independent response
resulted from heightened bacterial burdens observed
in MyD88 KO animals at this interval post-infection
(Figure 1).
Neutrophil and macrophage infiltration and activation
into C. koseri-infected brain parenchyma is attenuated in
MyD88 KO mice
The differential impact of MyD88 signaling on chemo-
kine expression at 12 versus 24 h post-infection led us
to examine whether these changes correlated with
alterations in peripheral immune cell influx. To quanti-
tate the potential differences in neutrophils, macro-
phages, and microglia between MyD88 KO and WT
mice, three-color FACS analysis was utilized. A dramatic
reduction in neutrophil and macrophage infiltrates was
observed in MyD88 KO mice at 12 h following C. koseri
exposure (data not shown), which correlated with the
diminished chemokine expression observed at this time
point (Figure 2). Interestingly, neutrophil and macro-
phage influx remained significantly lower in MyD88 KO
compared to WT animals at 24 h post-infection (Figure
3), which contrasted with the heightened chemokine
expression observed at this interval (Figure 2). The per-
centage of microglia recovered following C. koseri infec-
tion was also significantly attenuated in MyD88 KO
mice, which may be a consequence of the extensive
necrosis that accompanied infection in these animals. In
addition, Iba-1 staining revealed that macrophage/
microglial reactivity was attenuated in MyD88 KO
animals (Figure 4), which corroborates the decreased
percentages of each as revealed by FACS.
To determine whether viable abscess-associated neu-
trophils, macrophages, or microglia recovered from the
infected CNS of MyD88 KO or WT mice displayed any
differences in inflammatory mediator expression, we
performed microbead array analysis on conditioned
supernatants from each cell type following a 24 h incu-
bation period in vitro without bacterial re-stimulation,
in an attempt to capture cellular activation states that
were ongoing in vivo. MyD88 was important for eliciting
microglial proinflammatory mediator release during
CNS C. koseri infection as demonstrated by decreased
production of CXCL1, CXCL2, CCL3, CCL4, and IL-6
(Figure 5A). This finding agrees with our previous
report where MyD88-dependent signaling was shown to
be important for microglial activation in response to C.
koseri in vitro [27]. Similarly, macrophage activation in
response to CNS C. koseri infection was also influenced
by MyD88 as revealed by attenuated CXCL1, CXCL2,
and IL-6 production (Figure 5B). Infiltrating neutrophils
associated with C. koseri infected brain also required
MyD88-dependent activation signals for proinflamma-
tory mediator release (Figure 5C). None of these differ-
ences in cytokine/chemokine expression between cell
types recovered from MyD88 KO versus WT mice
reached statistical significance, although trends towards
reduced mediator levels were observed in all three
populations. The failure to detect significant changes
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obtained across experiments as well as sizable deviations
that cannot be avoided given biological variability. Col-
lectively, these results demonstrate that MyD88-depen-
dent signals are not only important for immune cell
recruitment but also their subsequent activation in
response to CNS C. koseri infection.
Regulation of bacterial burdens and inflammatory
mediator expression during CNS C. koseri infection are
TLR4-independent
Since TLR4 has been identified as a key sensor for host
defense in several models of Gram-negative infection
[28,29] and we observed a dramatic phenotype following
C. koseri infection in MyD88 KO mice, the contribution
of TLR4-mediated signal(s) was next examined. Com-
pared to WT mice, TLR4 mutant animals exhibited
slightly lower survival rates following C. koseri infection
(Figure 6A). The differences in mortality rates observed
for MyD88 and TLR4 WT animals can best be
explained by the different genetic backgrounds of the
two strains (C57BL/6 and C3H, respectively). Indeed,
there are several examples in the literature where differ-
ences in strain sensitivity to pathogens have been
demonstrated, most attributable to variations in MHC
haplotype [30-33]. Although there was a tendency
towards elevated bacterial titers in the ipsilateral and
contralateral hemispheres of TLR4 mutant mice at days
3 and 7 post-infection (Figure 6B and 6C, respectively),
these differences did not reach statistical significance in
a total of five independent experiments (data not
shown).
To evaluate whether TLR4 signaling impacted the
inflammatory milieu following C. koseri infection,
Figure 1 MyD88-dependent signals are essential for C. koseri containment during CNS infection. MyD88 WT and KO mice (triangles and
circles, respectively; 3-4 per group) received intracerebral injections of C. koseri (3.4 × 10
4 cfu), whereupon the number of viable bacteria in
either the injected (A) or contralateral (B) hemispheres were determined at 12 or 24 h post-infection. Bacterial burdens are expressed the colony
forming units (cfu) of C. koseri per gram of wet tissue weight (each data point represents an individual animal) and significant differences
between MyD88 KO and WT mice are denoted by asterisks (*, t-test, p < 0.05). Identification of C. koseri localization by Gram staining revealed
heightened numbers of extracellular bacteria (arrows, 100×) associated with the infected hemispheres of MyD88 KO (D) compared to WT (C)
animals at 24 h post-infection. Results are representative of three independent experiments with a total of 3-6 mice/group/study.
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using a microbead array. In general, chemokine expres-
sion was significantly higher at day 3 compared to day 7
post-infection, regardless of mouse strain (Figure 7A
and 7B). Only CXCL10 expression was significantly atte-
nuated in TLR4 mutant mice at day 3 post-infection
Figure 2 Proinflammatory mediator production following CNS C. koseri infection is influenced by both MyD88-dependent and
-independent signals. MyD88 WT and KO mice (4-6 per group) received intracerebral injections of C. koseri (3.4 × 10
4 cfu), whereupon
supernatants were prepared from infected hemispheres and cytokine/chemokine expression evaluated using multiplex microbead arrays for IL-1b
(A), TNF-a (B), IL-6 (C), CXCL1 (D), CXCL2 (E), CXCL10 (F), CCL2 (G), and CCL5 (H). Cytokine/chemokine expression was normalized based on the
amount of total protein obtained for each sample to correct for differences in tissue sampling size. Significant differences in mediator expression
between MyD88 WT and KO mice at 12 h post-infection are denoted by asterisks (*, p < 0.05, **, p < 0.01, t-test), whereas significant differences
in mediator levels between MyD88 WT and KO animals at 24 h post-infection are denoted by hatched signs (#, p < 0.05, ##, p < 0.01, t-test).
Results are representative of two independent experiments with a total of 3-6 mice/group/study.
Figure 3 Neutrophil and macrophage influx into C. koseri-
infected brain is dictated by MyD88-dependent signaling.
MyD88 KO and WT mice (5-8 per group) received intracerebral
injections of C. koseri and were sacrificed at 24 h following bacterial












quantitated by FACS analysis with the vital stain 7-AAD. Results are
expressed as the percentage of cells normalized to WT values (set
to 100%) and represent the mean ± SEM from three independent
experiments. Significant differences between MyD88 KO versus WT
mice are denoted by asterisks (*, p < 0.05, **, p < 0.01, t-test).
Figure 4 Microglial/macrophage activation in response to C.
koseri infection is impaired in MyD88 KO mice. MyD88 KO and
WT mice (6 per group) were sacrificed at 24 h following C. koseri
exposure, whereupon brain tissues were fixed by paraformaldehyde
perfusion and processed for cryostat sectioning. Ten μm thick brain
sections were subjected to immunofluorescence staining using Iba-
1 (green) and imaged by confocal microscopy (magnification, 10×).
Results are representative of six independent animals per group.
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ing CCL2, CXCL1, and IL-1b were similar between
TLR4 mutant and WT mice across all time points
examined (Figure 7). The similarity in proinflammatory
mediator expression between WT and TLR4 mutant
mice are in agreement with the nearly equivalent bacter-
ial burdens (Figure 6B and 6C). Collectively, these find-
ings indicate that TLR4-mediated signaling does not
play a major role in controlling C. koseri infection and
the resultant inflammatory response, at least under the
conditions examined in the present study.
MyD88, but not TLR4, is essential for astrocyte
chemokine production in response to C. koseri
Astrocytes are capable of bacterial recognition and serve
as a major source of chemokines in response to CNS
infection/injury [13,14,24]. To date, no studies have
demonstrated whether astrocytes are responsive to C.
koseri, which is relevant since astrocytes are the most
numerous cell type in the CNS and would directly
encounter bacteria during CNS colonization at the
blood-brain barrier as well as within the parenchyma.
O n l yaf e wr e p o r t sh a v ee x a m i n e dt h er o l eo fM y D 8 8 -
dependent signaling in astrocytes; however, this was in
response to purified PAMPs or LCMV [34-36] and not
an intact bacterium such as C. koseri, which presents
cells with a complex milieu of PAMPs. Both NO and
CXCL2 production were significantly inhibited in
MyD88 KO astrocytes compared to WT cells (Figure 8),
indicating that MyD88-dependent pathway(s) are critical
for transducing signals required for the production of
these inflammatory mediators by astrocytes.
To assess the functional importance of TLR4 in indu-
cing astrocytic inflammatory mediator production in
response to C. koseri, we compared responses of WT
and TLR4 mutant astrocytes enriched by FACS analysis
to remove residual contaminating microglia because of
the controversy regarding TLR4 expression in astrocytes
[37-39]. Both CCL2 and CXCL2 production was equiva-
lent between WT and TLR4 mutant astrocytes in
response to heat-inactivated C. koseri (Figure 9A and
9B, respectively), suggesting C. koseri recognition by
astrocytes is TLR4-independent. Importantly, IL-1b and
TNF-a were below the limit of detection by ELISA
(data not shown) indicating that C. koseri is not strong
inducer of cytokine expression in astrocytes.
As virulence factors produced by viable C. koseri may
contribute to astrocyte activation via pathways distinct
from those elicited by heat-inactivated bacteria, we next
studied astrocyte responses to live C. koseri. Similarly,
astrocyte activation by live C. koseri was also TLR4-
independent (Figure 9D and 9E). Neither heat-inacti-
vated nor live C. koseri led to significant changes in
astrocyte viability as revealed by MTT assays (Figure 9C
and 9F, respectively). Taken together, these data suggest
that enriched astrocytes recognize C. koseri and respond
with robust production of chemokines in a MyD88-
dependent, TLR4-independent manner.
Discussion
C. koseri is a Gram-negative pathogen that can cause
meningitis and ventriculitis, which frequently invades
the surrounding brain parenchyma resulting in multiple
abscesses [1,2]. Although a few reports have examined
v a r i o u sa s p e c t so fC. koseri meningitis/brain abscess in
rodent models [40-42], little is known regarding the
mechanism(s) responsible for bacterial recognition and
inflammatory responses within the CNS. In addition, the
impact of TLR signaling in CNS Gram-negative infec-
tions has received less attention compared to the num-
ber of studies focusing on Gram-positive pathogens
[7,8,21]. This is an important point since recent evi-
dence indicates that cytokine responses are tailored for
specific pathogen classes and are not relegated to a “one
Figure 5 MyD88 signaling regulates inflammatory mediator production by microglia and infiltrating immune cells associated with
CNS C. koseri infection. Viable microglia (A), macrophages (B), and neutrophils (C) were recovered from lesions of MyD88 KO and WT mice at
24 h following C. koseri infection by FACS based on exclusion of the vital dye 7-AAD. Cells were cultured overnight without additional
stimulation and conditioned supernatants were analyzed for mediator expression by multi-analyte microbead arrays. The amount of each
cytokine/chemokine was normalized based on total cell numbers and represents the mean ± SEM from three independent experiments.
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lighted by comparing the current study with an earlier
report from our laboratory where CNS infection with S.
aureus was examined. Both utilized MyD88 KO mice;
however, here we demonstrate that C. koseri was capable
of eliciting cytokine/chemokine production via MyD88-
independent pathways, whereas S. aureus recognition
was strictly MyD88-dependent [6]. Another distinction
was that MyD88 was essential for C. koseri containment,
whereas this was not the case with S. aureus where bac-
terial titers were similar between MyD88 KO and WT
mice [6]. Similar differences between MyD88 involve-
ment in CNS C. koseri versus S. aureus infection were
observed in a follow up study from our group. Namely,
MyD88-dependent signaling was critical in CNS intrin-
sic cells to generate maximal innate immune responses
during CNS S. aureus infection, whereas little impact of
MyD88-independent pathways was observed [43]. How-
ever, we did find that astrocytic chemokine induction
following C. koseri stimulation was MyD88-dependent,
suggesting some degree of conservation between patho-
gen sensing mechanisms. Collectively, these findings
highlight the ability of CNS immune mechanisms to dis-
criminate between Gram-positive versus -negative spe-
cies. The level of sophistication for pathogen
recognition (i.e. whether distinctions can be made
within similar pathogen classes) remains to be
determined.
Our results revealed an intriguing dichotomy for
MyD88-dependent signals in regulating host immunity
during CNS C. koseri infection. Specifically, MyD88 was
pivotal for inducing proinflammatory mediator release
immediately following bacterial exposure (i.e. 12 h);
however, within 24 h a transition occurred to elicit
these same mediators via a MyD88-independent
mechanism, with cytokine/chemokine levels in MyD88
KO mice exceeding those detected in infected WT ani-
mals. This deferred induction of MyD88-independent
effects is in agreement with the delayed kinetics of this
signaling pathway as reported by others [44,45]. How-
ever, it was apparent that the elevated MyD88-indepen-
dent proinflammatory response elicited in KO mice at
24 h was unable to impact C. koseri clearance since bac-
terial burdens were significantly elevated in MyD88 KO
compared to WT mice, reaching approximately 3-log
higher levels in the former. However, another interpreta-
tion is that MyD88-mediated responses increase anti-
inflammatory mediator expression that would normally
repress potentially damaging inflammation while pro-
moting the production of anti-microbial substances. In
this case, MyD88 loss would be expected to attenuate
anti-inflammatory mediator release, allowing the
MyD88-independent production of damaging molecules
to remain unchecked. However, we did not observe any
Figure 6 TLR4 has minimal impact on the course of CNS C.
koseri infection. TLR4 WT and TLR4 mutant mice (triangles and
circles, respectively; 4-5 per group) received intracerebral injections
of C. koseri (2.8 × 10
4 cfu) to induce meningitis and brain abscess
formation. Survival rates of WT and TLR4 mutant mice were 100%
and 84%, respectively (A). TLR4 WT or TLR4 mutant (Mut) mice were
euthanized at days 3 or 7 post injection (4-5 mice per group),
whereupon the number of viable bacteria in either the injected (B)
or contralateral (C) hemispheres were determined. Bacterial burdens
are expressed as colony forming units (cfu) of C. koseri per gram of
wet tissue weight (each data point represents an individual animal).
Results are representative of three independent experiments with a
total of 4-6 mice/group/study.
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or WT mice at either time point following C. koseri
infection (data not shown). Nonetheless, we cannot
exclude the possibility that alternative immune suppres-
sive mediators not examined here (i.e. TGF-b,s u p p r e s -
sor of cytokine signaling (SOCS) proteins) are driven by
MyD88-dependent signaling, and the absence of these
molecules exacerbates late stage C. koseri inflammatory
responses. With regard to the mechanism(s) responsible
for eliciting MyD88-independent inflammation during
C. koseri infection, one possibility is signaling via the
alternative adaptor molecule TRIF. Indeed, activation of
TRIF-dependent signaling leads to the expression of
IFN-inducible genes and late phase NF-B activation
[17,46]. However, the only TLRs that utilize TRIF are
TLR3 and TLR4 and the former is likely not involved in
C. koseri recognition since its ligand, dsRNA, is typical
of viral infections [47]. Likewise, our results demonstrate
a minor role for TLR4 in terms of eliciting proinflam-
matory mediator release and bacterial containment.
Therefore, the contribution of TRIF towards the
MyD88-independent proinflammatory response during
C. koseri CNS infection remains uncertain. Other poten-
tial candidates include the cytoplasmic PRRs NOD1 and
Figure 7 Proinflammatory mediator production in response to CNS C. koseri infection is primarily TLR4-independent. TLR4 WT and TLR4
mutant mice (4-5 per group) received intracerebral injections of C. koseri (2.8 × 10
4 cfu), whereupon supernatants were prepared from infected
hemispheres and cytokine/chemokine expression evaluated using multiplex microbead arrays for CCL2 (A), CXCL1 (B), IL-1b (C), and CXCL10 (D).
Cytokine/chemokine expression was normalized based on the amount of total protein obtained for each sample to correct for differences in
tissue sampling size. Significant differences in mediator expression between days 3 and 7 post-infection are denoted by asterisks (*, p < 0.05,
One-Way ANOVA), whereas the difference in CXCL10 levels between TLR4 WT mice and TLR4 mutant mice at day 3 post-infection is denoted by
a hatched sign (#, p < 0.05, One-Way ANOVA). Results are representative of three independent experiments with a total of 4-6 mice/group/study.
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Page 10 of 14Figure 8 MyD88-dependent signals play a pivotal role in mediating astrocytic inflammatory mediator release in response to C. koseri.
Primary astrocytes recovered from MyD88 WT or KO mice were plated at 1 × 10
5 cells/well in 96-well plates and exposed to heat-inactivated C.
koseri (10
7 cfu/well) for 24 h. The levels of NO (A) and CXCL2 (B) produced by astrocytes were quantitated by nitrite assay and ELISA,
respectively. Astrocyte viability was assessed by a standard MTT assay and the raw OD570 absorbance values are reported (C). Significant
differences in inflammatory mediator expression between C. koseri stimulated MyD88 KO and WT astrocytes are denoted by asterisks (* p < 0.05;
** p < 0.001, t-test). Results are reported as the mean ± SD of three independent wells for each experimental treatment and were identical
across three separate experiments.
Figure 9 Astrocyte activation in response to heat-inactivated or viable C. koseri is TLR4-independent. FACS-enriched WT and TLR4
mutant astrocytes were plated at 1 × 10
5 cells/well in 96-well plates and exposed to either heat-inactivated C. koseri (10
7 cfu/well) for 24 h (A, B,
C), or live C. koseri at a multiplicity of infection (MOI) of 1 for 6 h (D, E, F). CCL2 (A and D) and CXCL2 (B and E) production was quantitated by
ELISA. Astrocyte viability was assessed using a MTT assay and the raw OD570 absorbance values are reported (C, F). There were no significant
differences in chemokine release between WT and TLR4 mutant astrocytes. Results are reported as the mean ± SD of three independent wells
for each experimental treatment and were identical across six separate experiments.
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been implicated in the recognition of flagellated bacteria
such as Ipaf and Naip [48-50]. However, the involve-
ment of these alternative PRRs in regulating proinflam-
matory mediator release during CNS C. koseri infection
waits testing in future studies.
One unexpected finding was that elevated chemokine
expression in MyD88 KO animals at 24 h post-infection
did not translate into enhanced immune cell recruit-
ment. Rather, neutrophil and macrophage infiltrates
remained significantly attenuated in MyD88 KO mice
compared to WT animals. The reason for this finding is
unclear; however, since multiple events are required for
immune cell extravasation across the blood-brain bar-
rier, it is possible that another phase is aberrant in
MyD88 KO mice. For example, early IL-1b and TNF-a
production is important for inducing adhesion molecule
expression on BBB endothelial cells [51-53]. Since the
production of both cytokinesi ss i g n i f i c a n t l yb l u n t e d
early in MyD88 KO animals, sufficient time would be
required to induce adhesion molecule expression to
overcome the migration block. In this case, by the time
that IL-1b and TNF-a were upregulated in MyD88 KO
animals, this may prove too late to impact immune cell
migration into the CNS. Yet, even those neutrophils and
macrophages that were recruited to the site of infection
in MyD88 KO mice were less activated as revealed by
reduced levels of cytokine/chemokine production. It is
possible that the residual recruitment of these leukocyte
subsets in MyD88 KO animals resulted from alternative
chemotactic factors such as microbial-derived peptides
(i.e. formyl peptides) or complement split products (i.e.
C3a or C5a). However, once these cells enter the CNS
parenchyma they are unable to effectively respond to C.
koseri due to the lack of MyD88 signaling. Since heigh-
tened inflammatory mediator release was evident in
brain abscess homogenates but not purified immune cell
populations at 24 h post-infection, this suggests MyD88-
independent contributions from alternative cell types,
the identity of which remains unknown at the present
time.
The host possesses multiple redundant mechanisms to
ensure rapid immune responses to pathogens and infec-
tion resolution [9,10,48,54]. When taken together, our
results strongly suggest a collaborative role for numer-
ous recognition pathways in generating a potent anti-
bacterial immune response to CNS C. koseri infection.
First, since the majority of TLRs utilize MyD88 as an
adaptor, MyD88 deficiency will globally abolish all TLR-
mediated signals in addition to signaling via the IL-1R
and IL-18R. This is particularly relevant since C. koseri
harbors numerous ligands that can stimulate MyD88-
dependent TLR signaling including lipoproteins (TLR2),
LPS (TLR4), flagella (TLR5), and CpG DNA (TLR9) as
well as the ability of C. koseri to elicit IL-1b release dur-
ing CNS infection (Figure 2). In addition to TLRs, cyto-
p l a s m i cP R R ss u c ha sN L R T C 4a n dN A I Pt h a ta r e
activated by flagellin [48] could also contribute to proin-
flammatory mediator production since C. koseri is a fla-
gellated bacterium; however, this possibility remains
speculative.
The concept of receptor redundancy for eliciting max-
imal responses to C. koseri was also evident when exam-
ining primary astrocytes isolated from MyD88 KO or
TLR4 mutant mice. Similar to our in vivo observations,
chemokine production was negligible in MyD88 KO
astrocytes in response to intact bacteria, whereas TLR4
mutant cells responded identically to their WT counter-
parts. This indicates that MyD88-dependent receptors
are critical for astrocyte activation and potential candi-
dates include TLR2, TLR5, and TLR9 that recognize
lipoproteins, flagellin, and CpG DNA, respectively.
Although it is clear that TLR4 is not involved in astro-
cyte responses to intact C. koseri,t h ee x t e n to fT L R 4
expression in astrocytes and whether it plays a role in
LPS sensing remains controversial [37-39]. This issue
has been hampered by the poor quality of commercially
available TLR4 antibodies in the mouse as well as con-
cerns regarding the purity of primary astrocyte cultures
[ 2 5 ] .H o w e v e r ,a st h i st o p i cw a sn o tt h ef o c u so ft h e
current report, future studies using highly purified astro-
cytes obtained by FACS analysis or alternative methods
such as positive selection via magnetic beads are needed
to address these issues related to LPS responsiveness.
In summary, MyD88 is crucial for eliciting a protec-
tive host immune response during C. koseri brain infec-
tion. Despite a late-phase induction of MyD88-
independent signaling to trigger proinflammatory
release, this response was not sufficient to negate
uncontrolled bacterial replication and lethality in
MyD88 KO animals. The fact that TLR4 had little
impact on the course of infection strongly suggests the
involvement of alternative TLRs as well as the IL-1R
and IL-18R, which also utilize MyD88 as an adaptor.
T h ei d e n t i t yo ft h e s ea l t e r n a t i v eM y D 8 8 - d e p e n d e n t
receptors remains the topic for future studies.
Additional material
Additional file 1: Astrocyte enrichment by sub-culturing and FACS.
Primary astrocytes were sub-cultured by shaking and passage three times
before collection. Astrocytes were harvested by trypsinization and stained
with a CD11b antibody conjugated to PerCP-Cy5.5. The majority of cells
recovered from astrocyte flasks were CD11b-negative, with an average of
3-10% contaminating CD11b-positive microglia (A). Residual CD11b-
positive cells were depleted from astrocytes by sorting, as indicated by
post-sort analysis (B). Purified microglia were included as a positive
control for CD11b staining (C). Subsequently, sorted astrocytes were
plated on cover slips at a density of 1 × 10
4 cells/ml. After 24 h, cells
were stained for GFAP (D) and Iba-1 (E) to visualize astrocytes and
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Page 12 of 14residual microglia, respectively. Purified microglia were stained with Iba-1
as positive control (F).
Additional file 2: Establishment of CNS C. koseri infection and brain
abscess formation. (A) C57BL/6 mice (4-5 per group) were used to
optimize C. koseri infectious doses and survival rates out to day 7 post-
infection are presented. (B) A brain abscess induced by C. koseri at day 7
post-infection is shown (arrows; magnification, 12.5×).
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